Drug-eluting stent litigation
This article was originally published in The Gray Sheet
Executive Summary
Wilmington, Del. federal court schedules June 2005 hearing of patent infringement suits exchanged between Boston Scientific and Johnson & Johnson. Judge Sue Robinson rejected requests for injunctions against sales by both firms last November; however, she noted J&J has a "likelihood of success on the merits" of the case (1"The Gray Sheet" Dec. 1, 2003, p. 17)...
You may also be interested in...
Taxus Clears Legal Hurdle As Judge Denies J&J/Cordis Injunction Request
The arguments made by Boston Scientific and Johnson & Johnson/Cordis in the ongoing drug-eluting stent patent dispute both have merit, according to Wilmington, Del. federal court Judge Sue Robinson
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.